Neuromuscular complications of critical illness

Neurologist

Volumn 6, Issue 1, 2000, Pages 2-11

  Bird, Shawn J ^a,c   Rich, Mark M ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b EMORY CLINIC   (United States)

^c HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Acute quadriplegic myopathy; Critical illness; Critical illness polyneuropathy; Muscle membrane inexcitability; Weakness

Indexed keywords

ATRACURIUM; CORTICOSTEROID; MYOSIN; NEUROMUSCULAR BLOCKING AGENT; PANCURONIUM; SODIUM CHANNEL; SODIUM ION; VECURONIUM;

CRITICAL ILLNESS; HUMAN; MULTIPLE ORGAN FAILURE; MUSCLE WEAKNESS; MYOFILAMENT; MYOPATHY; NEUROMUSCULAR BLOCKING; NEUROMUSCULAR DISEASE; NONHUMAN; POLYNEUROPATHY; PRIORITY JOURNAL; REVIEW; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 0033982932     PISSN: 10747931     EISSN: None     Source Type: Journal    
DOI: 10.1097/00127893-200006010-00002     Document Type: Review

References (52)

1. Spitzer AR, Giancarlo T, Maher L, Awerbuch G, Bowles A. Neuromuscular causes of prolonged ventilator dependency. Muscle Nerve 1992;15:682-6.
2. Lacomis D, Petrella JT, Giuliani MJ. Causes of neuromuscular weakness in the intensive care unit: A study of ninety-two patients. Muscle Nerve 1998;21:610-7.
3. Bolton CF, Gilbert JJ, Hahn AF, Sibbald WJ. Polyneuropathy in critically ill patients. J Neurol Neurosurg Psychiatry 1984;47:1223-31.
4. Bolton CF. Critical illness polyneuropathy: A useful concept. Muscle Nerve 1999;22:419-22.
5. Raps EC, Bird SJ, Hansen-Flaschen J. Prolonged muscle weakness after neuromuscular blockade in the intensive care unit. Crit Care Clin 1994;10:799-813.
6. Lacomis D, Giuliani MJ, Van Cott A, Kramer DJ. Acute myopathy of intensive care: Clinical, electromyographic, and pathological aspects. Ann Neurol 1996;40:645-54.
7. Bolton CF. Critical illness polyneuropathy. In Thomas PK, Asbury AK, editors. Peripheral Nerve Disorders 2. Boston: Butterworth-Heinemann, 1995:262-80.
8. Bolton CF, Laverty DA, Brown JD, Witt NJ, Hahn AF, Sibbald WJ. Critically ill polyneuropathy: Electrophysiological studies and differentiation from Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry 1986;49:563-73.
9. Bolton CF. Electrophysiologic studies of critically ill patients. Muscle Nerve 1987;10:129-35.
10. Williams AC, Sturman S, Kelsey S, Curran FT, Finnegan JA. The neuropathy of the critically ill. BMJ 1986;293:790-8.
11. Witt NJ, Zochodne DW, Bolton CF, Grand'Maison F, Wells G, Young B, et al. Peripheral nerve function in sepsis and multiple organ failure. Chest 1991;99:176-84.
12. Zochodne DW, Bolton CF, Gilbert JJ. Polyneuropathy in critical illness: Pathologic features. Ann Neurol 1985;18:160-6.
13. Zochodne DW, Bolton CF, Wells GA, Gilbert JJ, Hahn AF, Brown JD, et al. Critical illness polyneuropathy. Brain 1987;110:819-12.
14. Tran DD, Groeneveld ABJ, Van Der Meuien J. Age, chronic disease, sepsis, organ system failure, and mortality in a medical intensive care unit. Crit Care Med 1990;18:474-9.
15. American College of Chest Physicians Consensus Conference. Definition for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992;20:864-74.
16. Bleck TP, Smith MC, Pierre-Louis SJ, Murray J, Hansen CA. Neurologic complications of critical medical illness. Crit Care Med 1993; 21:98-103.
17. Kelly BJ, Mathay MA. Prevalence and severity of neurologic dysfunction in critically ill patients: influence on need for continued mechanical ventilation. Chest 1993;104:1818-24.
18. Leijten FSS, Harinck-De Weerd JE, Poortvliet DCJ, De Weerd AW. Critical illness polyneuropathy in multiple organ dysfunction syndrome and weaning from the ventilator. Intensive Care Med 1996; 22:856-61.
19. Berek K, Margreiter J, Willeit J. Polyneuropathies in critically ill patients: A prospective evaluation. Intensive Care Med 1993;22:849-55.
20. Teener JW, Rich MM, Bird SJ. Other causes of acute weakness in the intensive care unit. In Miller DH, Raps EC, editors. Critical care neurology. Boston: Butterworth-Heinemann, 1999:69-89.
21. Glauser MP, Zanetti G, Baumgartner JD, Cohen J. Septic shock: Pathogenesis. Lancet 1991;338:732-5.
22. Bolton CF. Clinical neurophysiology of the respiratory system. Muscle Nerve 1993;16:809-18.
23. MacFarlane IA, Rosenthal FD. Severe myopathy after status asthmaticus. Lancet 1977;2:615.
24. Rich MM, Bird SJ, Raps EC, McCluskey LF, Teener JW. Direct muscle stimulation in acute quadriplegic myopathy. Muscle Nerve 1997;20:665-73.
25. Showalter CJ, Engel AG. Acute quadriplegic myopathy: Analysis of myosin isoforms and evidence for calpain-mediated proteolysis. Muscle Nerve 1997;20:316-22.
26. Latronico N, Fenzi F, Recupero D, Tomelleri G, Tonin P, De Maria G, et al. Critical illness myopathy and neuropathy. Lancet 1996;347: 1570-82.
27. Op de Coul AAW, Lambregts PCLA, Koeman J, van Puyenbroek MJE, Ter Laak HJ, Gabreels-Festen AAWM. Neuromuscular complications in patients given Pavulon (pancuronium bromide) during artificial ventilation. Clin Neurol Neurosurg 1985;87:17-22.
28. Zochodne DW, Ramsay DA, Saly V, Shelley S, Moffatt S. Acute necrotizing myopathy of intensive care: Electrophysiological studies. Muscle Nerve 1994;17:285-92.
29. Rich MM, Teener JW, Raps EC, Schotland DL, Bird SJ. Muscle is electrically inexcitable in acute quadriplegic myopathy. Neurology 1996;46:731-6.
30. Buchthal F, Engbaek L, Gamstorp I. Paresis and hyperexcitability in adynamia episodica hereditaria. Neurology 1958;8:347-51.
31. Layzer RB, Lovelace RE, Rowland LP. Hyperkalemic periodic paralysis. Arch Neurol 1967;16:457-72.
32. Rich MM, Pinter MJ, Kraner SD, Barchi RL. Loss of electrical excitability in an animal model of acute quadriplegic myopathy. Ann Neurol 1998;43:171-9.
33. Berg DK, Hall ZW. Increased extrajunctional acetylcholine sensitivity produced by chronic acetylcholine sensitivity produced by chronic post-synaptic neuromuscular blockade. J Physiol 1975;244:659-76.
34. Ji S, Sun W, George AL, Horn R, Barchi RL. Voltage-dependent regulation of nodal gating in the rat SkM1 sodium channel expressed in Xenopus oocytes. J Gen Physiol 1994;104:625-43.
35. Pappone PA. Voltage-clamp experiments in normal and denervated mammalian skeletal muscle fibers. J Physiol 1980;306:377-410.
36. Wang DW, George AL, Bennett PB. Comparison of heterologously expressed human cardiac and skeletal muscle sodium channels. Biophys J 1996;70:238-45.
37. White MM, Chen LQ, Kleinfield R, Kallen RG, Barchi RL. SkM2, a Na+ channel cDNA clone from denervated skeletal muscle, encodes a tetrodotoxin-insensitive Na+ channel. Mol Pharmacol 1991; 39:604-8.
38. Yang JS, Sladky JT, Kallen RG, Barchi RL. TTX-sensitive and TTX-insensitive sodium channel mRNA transcripts are independently regulated in adult skeletal muscle after denervation. Neuron 1991;7:421-7.
39. Bizzard-Scmid MD, Desai SP. Prolonged neuromuscular blockade with atracurium. Can Anaesth Soc J 1986;33:209-12.
40. O'Connor M, Russell WJ. Muscle strength following anaesthesia with atracurium and pancuronium. Anaesth Intensive Care 1988;16:255-9.
41. Partridge BL, Abrams JH, Bazemore C, Rubin R. Prolonged neuromuscular blockade after long-term infusion of vecuronium bromide in the intensive care unit. Crit Care Med 1990;18:1177-80.
42. Segredo V, Caldwell JE, Matthay MA, Sharma ML, Gruenke LD, Miller RD. Persistent paralysis in critically ill patients after long-term administration of vecuronium. N Engl J Med 1992;327:524-5.
43. Vanderheyden BA, Reynolds HN, Gerold KB, Emanuele T. Prolonged paralysis after long-term vecuronium infusion. Crit Care Med 1992;20:304-6.
44. Hansen-Flaschen JH, Brazinsky S, Basile C, Lanken PN. Use of sedating drugs and neuromuscular blocking agents in patients requiring mechanical ventilation for respiratory failure: A national survey. JAMA 1991;266:2870-5.
45. Breuer AC. Critical illness polyneuropathy: An outdated concept. Muscle Nerve 1999;22:422-4.
46. Bolton CF. Sepsis and the systemic inflammatory response syndrome: Neuromuscular manifestations. Crit Care Med 1996;24:1408-16.
47. Rich MM, Teener JW, Raps E, Bird S. Muscle inexcitability in patients with reversible paralysis following steroids and neuromuscular blockade. Muscle Nerve 1999. In press.
48. Bird SJ, Mackin GA, Schotland DL, Raps EC. Acute myopathic quadriplegia: A unique syndrome associated with vecuronium and steroid treatment [abstract]. Muscle Nerve 1992;15:1208.
49. Road J, Mackie G, Jiang T, Stewart H, Eisen A. Reversible paralysis with status asthmaticus, steroids, and pancuronium: Clinical electrophysiological correlates. Muscle Nerve 1997;20:1587-90.
50. Hund E, Genzwurker H, Bohrer H, Jakob H, Thiele R, Hacke W. Predominant involvement of motor fibres in patients with critical illness polyneuropathy. Br J Anaesth 1997;78:274-8.
51. Schwarz J, Planck J, Briegel J, Straube A. Single-fiber electromyography, nerve conduction studies, and conventional electromyography in patients with critical-illness polyneuropathy: evidence for a lesion of terminal motor axons. Muscle Nerve 1997;20:696-701.
52. Ramsay DA, Zochodne DW, Robertson DM, Nag S, Ludwin SK. A syndrome of acute severe muscle necrosis in intensive care unit patients. J Neuropathol Exp Neurol 1993;52:387-98.